Patents by Inventor AMELIE ARGENTO-PUCCIARELLI

AMELIE ARGENTO-PUCCIARELLI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • High throughput and functional screening method for muscle related disorders and biological processes
    Patent number: 11061017
    Abstract: The invention relates to a method for high throughput screening compounds by using a plurality of automated cell based assays assessing skeletal muscle cells contractility, morphology, and metabolism, in order to predict the efficacy of said compound on a panel of applications linked with muscle physiological and pathophysiological processes, comprising: (i) providing an in vitro culture of myotubes, wherein the in vitro myotubes culture is obtained by the following method: providing a cell culture device allowing the culture of myoblasts or myotubes, depositing said cells from a human donor or human group of donors, in good health or affected by a muscle related disorder, from primary cells, a cell line, an isogenic cell line or differentiated stem cells recapitulating a muscle disorder, on said culture device by using a method allowing the spatial control of cell culture, culturing said cells during a determined incubation time so as to promote a spatially controlled myotube culture; (ii) adding at least on
    Type: Grant
    Filed: June 15, 2016
    Date of Patent: July 13, 2021
    Assignee: CYTOO
    Inventors: Sebastien Degot, Yoran Margaron, Amelie Argento-Pucciarelli, Eve Duchemin-Pelletier, Joris Michaud, Mathieu Fernandes, Pauline Poydenot
  • HIGH THROUGHPUT AND FUNCTIONAL SCREENING METHOD FOR MUSCLE RELATED DISORDERS AND BIOLOGICAL PROCESSES
    Publication number: 20180356400
    Abstract: The invention relates to a method for high throughput screening compounds by using a plurality of automated cell based assays assessing skeletal muscle cells contractility, morphology, and metabolism, in order to predict the efficacy of said compound on a panel of applications linked with muscle physiological and pathophysiological processes, comprising: (i) providing an in vitro culture of myotubes, wherein the in vitro myotubes culture is obtained by the following method: providing a cell culture device allowing the culture of myoblasts or myotubes, depositing said cells from a human donor or human group of donors, in good health or affected by a muscle related disorder, from primary cells, a cell line, an isogenic cell line or differentiated stem cells recapitulating a muscle disorder, on said culture device by using a method allowing the spatial control of cell culture, culturing said cells during a determined incubation time so as to promote a spatially controlled myotube culture; (ii) adding at least on
    Type: Application
    Filed: June 15, 2016
    Publication date: December 13, 2018
    Inventors: SEBASTIEN DEGOT, YORAN MARGARON, AMELIE ARGENTO-PUCCIARELLI, EVE DUCHEMIN-PELLETIER, JORIS MICHAUD, MATHIEU FERNANDES, PAULINE POYDENOT